Psoriasis-clearing drug gets FDA approval

| Melissa Leavitt

A new psoriasis drug that’s delivered dramatic skin improvement has been approved by the Food and Drug Administration (FDA).

Cosentyx (secukinumab), an injectable biologic drug manufactured by Novartis, has won approval for the treatment of chronic plaque psoriasis. In clinical trials, more than half of patients taking Cosentyx experienced clear or almost clear skin, while the majority experienced significant improvement.

In one trial, more than a quarter of patients achieved a 100 percent improvement in their skin, as measured by the Psoriasis Area and Severity Index. This measurement, also known as PASI 100, means that the patient had no psoriasis anywhere on their body. Almost 82 percent of patients in the same trial achieved 75 percent improvement, or PASI 75.

Other data on the drug indicate that the level of improvement delivered by Cosentyx can be long-lasting.

Results from another Phase III trial suggest that Cosentyx is also an effective treatment for psoriatic arthritis. Novartis plans to apply for FDA approval for Cosentyx as a psoriatic arthritis drug later this year.

Cosentyx targets interleukin-17A (IL-17A), which is a protein, or cytokine, that triggers inflammation. IL-17 is a key cytokine in psoriasis, and, according to the researchers, may even be a “master cytokine,” responsible for a series of inflammatory reactions.

Two other drugs targeting IL-17, brodalumab and ixekizumab, are also being developed as treatments for psoriasis.


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Capitol hill, advocacy, legislation
We will continue to advocate for better health care for psoriatic disease...
LITE study logo
A new clinical trial researching the effectiveness and safety of home-based...
cartoon of people studying giant book
NPF and the American College of Rheumatology release a pioneering treatment...
Psoriatic disease patient Ellen Clements
Ellen Clements overcomes flares, joint pain and bullies in the office to...
Michael Bentley on his radio
A Texas man finds the right specialists and gets approved for disability...
Leah McCormick Howard and Stephen Katz
Longtime NIAMS director was a friend to all he served.
cartoon two scientists with giant microscope and helix in background
You don’t need an advanced degree in biochemistry to be a Citizen Pscientist,...
Edgar Payano, psoriasis, Dominican
A Dominican-American man with psoriasis fends off the usual annoying questions...
NPF, Tide, Seal of Recognition, Proctor & Gamble
NPF awards Seal of Recognition to two Procter & Gamble Tide products.